The UK government just made a quiet but significant choice. For years, it promised a big, comprehensive AI Bill, with rules, rulebook, providing something clear.
Then in October 2025, it changed its mind entirely. Instead of rushing to create a standalone AI law, it chose a different approach.
The result is the proposed AI Growth Lab - a regulatory sandbox that would allow selected AI companies to test products under supervised conditions while regulators observe how they perform in the real world.
We believe, this initiative, changes everything about how UK founders build AI.But it also creates new risks nobody's fully talking about yet.
Why the government scrapped the rulebook
Traditional regulation generally moves slowly.
A government writes a law in 2024, and by the time it lands in 2026, the technology has already moved on.The UK decided to try something different, this time: with time-limited testing zones instead of one big rulebook for UK AI regulation.Here's how it works:You build an AI product, and you apply to test it under modified regulations.
If approved, you get a sandbox license.
Regulators should watch real-world data; if it works, the rule might change permanently.The approach is already working in healthcare.
The Medicines and Healthcare Products Regulatory Agency (MHRA) launched the AI Airlock in 2024, which is the world's first regulatory sandbox for AI medical devices.Its pilot wrapped in March 2025 with real learnings.
One project tested generative AI to draft radiologist conclusion sentencesee, those weekly design reviews helped refine safety guardrails.
So, this is a real sandbox, with real results and real learning.We think that's the bet the government is making with the AI Growth Lab: which is faster approvals beat perfect rules.
Why Fintech founders should pay attention
If you're building AI for finance, this is your moment.The FCA (Financial Conduct Authority) has already been running this playbook under FCA regulatory frameworks. They launched an "AI Live Testing" scheme in September 2025, where firms can test AI models in real conditions with synthetic data.In November 2025, they selected fintech startup Eunice, exploring how to improve transparency in crypto markets - as a sandbox participant.The money actually tells the real story: AI startups funding shows that companies in a growth sandbox attract 6.6 times more investment than those outside it. Time-to-market accelerates by roughly 40%.For fintech founders racing against European competitors stuck in the bureaucracy of the EU AI Act, that's a meaningful edge.Algorithmic trading.
Fraud detection.
KYC/AML automation.
All of these sit in grey zones today, which is technically risky and strategically important, but nobody knows exactly how the rules apply.
The Growth Lab provides a method to test them without risking the entire company.
Tom Lorimer, co-founder of Passion Labs (which worked inside the FCA sandbox), says:
"Done properly, it could finally give companies a direct, faster route to sign-off on AI deployments, especially in areas where UK regulation has a strong track record of slowing things down unnecessarily."
Healthcare is where this gets serious
If you're building diagnostic AI, the sandbox could unlock a path that currently doesn't exist.The NHS has enormous waiting lists and AI could cut them, it could accelerate cancer detection thus improving patient outcomes.
But medical device regulation wasn't written for algorithms that learn.
Current rules assume products stay static; they don't account for systems that improve themselves over time.The MHRA's AI Airlock gave them practice and now they're finally expanding it.We believe healthcare AI startups with real clinical value, that is - cancer detection, radiology automation, pathology analysis - are obvious candidates for the next phase of the AI Growth Lab.The downside? The approval timelines are still long.
But there is an upside - they're actually shorter than the old route, and you're building a relationship with regulators from day one.
Three things that should worry you
Number One: Liability is still unclear.If your Growth Lab AI system causes harm during testing, who pays? The regulatory exemption might protect you from fines. But actual liability, which is compensation, damages, and reputational fallout, isn't clearly defined yet.
Your insurance company probably doesn't know either.
Number Two: This regulation only applies to five sectors right now.Healthcare, professional services, transport, advanced manufacturing, fintech.If you're building recruitment AI, HR tech, ecommerce recommendations, or education tools, the sandbox doesn't immediately apply, but the government says it will expand.When? To what sectors? Nobody knows that yet.
Number Three: Parliament is watching.Lord Holmes, a House of Lords member and AI policy authority, raised concerns about what he calls "Henry VIII powers"- the idea that ministers can amend UK AI regulation via secondary legislation with minimal parliamentary debate. He's not against sandboxes. He's against giving ministers too much power to change rules without proper scrutiny. We believe governance clarity matters as much as regulatory speed.
What you need to do right now
If you're in fintech or healthcare, start mapping which regulations slow you down.Can you document everything? Can you handle regulatory scrutiny? Can you explain your safety approach clearly?Start building relationships with regulators now, before application windows open and before everyone else does.Talk to your investors, understand their expectations around timeline and liability. The sandbox accelerates approvals, but it doesn't eliminate risk.
The central tension
Here's what nobody's resolved:
We want AI approvals faster, but we also don't want unsafe AI in healthcare, transport, or finance because everyone was in a hurry.The Growth Lab's safeguards which includes,licensing, monitoring, the ability to stop a pilot are all designed to catch problems early, but they only work if regulators have enough resources and expertise.
Nik Kairinos, CEO of AI safety platform RAIDS AI, puts it plainly:
"Speed must be balanced with safety and foresight, as today's innovation can all too quickly become tomorrow's problem."
And we agree, the Growth Lab isn't a deregulation bonfire; it's a totally different bet, where regulators and founders learn together, in real time, with safeguards in place.Whether it works better than a traditional bill depends on the execution.
What happens next
Sandboxes are expected to roll out through 2026 and 2027; the application windows haven't been announced yet.We believe the next 12 months are critical: founders who understand their regulatory gaps, build regulator relationships, and prepare thoughtful pilot proposals will definitely have an advantage when the windows open.If you're in a target sector, start now; do not wait until September 2026 to think about this.The founders who move first will shape what the AI Growth Lab actually becomes.
The Bottom Line
The Growth Lab is not deregulation, nor is it necessarily faster; it just depends on your regulators and readiness, but it does represent something genuinely different: an admission from the UK government that comprehensive rules can't keep pace with AI progress.The sandbox is the bet that learning together works better than guessing in advance.We think that's worth trying, but whether it works depends entirely on you.
Sources: Data sourced from GOV.UK, Bird & Bird regulatory guidance, Hogan Lovells international policy analysis, MHRA AI Airlock documentation, FCA sandbox framework, Compliance Week, and GLACIS government policy releases.
All claims were verified against government announcements and regulatory body statements (October 2025 – January 2026).
